PERI-PROCEDURAL USE OF NOVEL ORAL ANTICOAGULATION AGENTS DURING CARDIAC DEVICE IMPLANTATION: ARE THEY SAFE?

Valay Parikh,Madhav Lavu,Venkat Vuddanda,Mohammad Jazayeri,Vidhya Reddy,Bhavya Yarlagadda,Himabindu Korra,Rakesh Venkata,Sudharani Bommana,Donita Atkins,Madhu Reddy,Dhanunjaya Lakkireddy

PERI-PROCEDURAL USE OF NOVEL ORAL ANTICOAGULATION AGENTS DURING CARDIAC DEVICE IMPLANTATION: ARE THEY SAFE?

2017

Valay Parikh
Madhav Lavu
Venkat Vuddanda
Mohammad Jazayeri
Vidhya Reddy
Bhavya Yarlagadda
Himabindu Korra
Rakesh Venkata
Sudharani Bommana
Donita Atkins
Madhu Reddy
Dhanunjaya Lakkireddy

Background: Safety of peri-procedural use of novel oral anticoagulation agents (NOACs) during cardiac device implantation has been suggested in small observational studies. Larger data affirming its safety is lacking. Methods: We performed a multicenter evaluation of safety of uninterrupted

Keywords:

Diabetes mellitus
Intensive care medicine
Cardiology
Anticoagulation Agents
Observational study
Internal medicine
Peri
Medicine
cardiac device
oral anticoagulation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations